Bo Gong

3.6k total citations
113 papers, 1.5k citations indexed

About

Bo Gong is a scholar working on Ophthalmology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Bo Gong has authored 113 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Ophthalmology, 46 papers in Molecular Biology and 22 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Bo Gong's work include Retinal Diseases and Treatments (27 papers), Glaucoma and retinal disorders (23 papers) and Corneal surgery and disorders (13 papers). Bo Gong is often cited by papers focused on Retinal Diseases and Treatments (27 papers), Glaucoma and retinal disorders (23 papers) and Corneal surgery and disorders (13 papers). Bo Gong collaborates with scholars based in China, Hong Kong and United States. Bo Gong's co-authors include Zhenglin Yang, Yi Shi, Lingxi Jiang, Chunbao Xie, Guo Huang, Ping Shuai, He Lin, Hong Pu, Hua Yu and Xiaoqi Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nano Letters and PLoS ONE.

In The Last Decade

Bo Gong

109 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bo Gong China 20 663 316 236 225 185 113 1.5k
Silvia Bartollino Italy 18 435 0.7× 227 0.7× 148 0.6× 77 0.3× 93 0.5× 38 1.1k
Yujuan Wang China 17 327 0.5× 323 1.0× 200 0.8× 156 0.7× 114 0.6× 91 1.3k
Yuqing Deng China 22 401 0.6× 270 0.9× 434 1.8× 61 0.3× 55 0.3× 95 1.6k
Zhaoxia Zhang China 18 431 0.7× 126 0.4× 134 0.6× 92 0.4× 151 0.8× 119 1.3k
Yongqing Tong China 21 354 0.5× 140 0.4× 66 0.3× 110 0.5× 111 0.6× 58 1.2k
José D. Luna Argentina 25 690 1.0× 1.3k 4.0× 696 2.9× 80 0.4× 178 1.0× 73 2.1k
Chandrasekharam N. Nagineni United States 31 1.5k 2.2× 747 2.4× 318 1.3× 41 0.2× 326 1.8× 54 2.9k
Akiko Iwata Japan 22 428 0.6× 117 0.4× 113 0.5× 101 0.4× 37 0.2× 66 1.2k
Brian C. Leonard United States 21 439 0.7× 333 1.1× 280 1.2× 54 0.2× 25 0.1× 81 1.3k
Xiaochun Wang China 21 568 0.9× 64 0.2× 219 0.9× 174 0.8× 336 1.8× 66 1.6k

Countries citing papers authored by Bo Gong

Since Specialization
Citations

This map shows the geographic impact of Bo Gong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Gong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Gong more than expected).

Fields of papers citing papers by Bo Gong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Gong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Gong. The network helps show where Bo Gong may publish in the future.

Co-authorship network of co-authors of Bo Gong

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Gong. A scholar is included among the top collaborators of Bo Gong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Gong. Bo Gong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Jing, Zhirui Zhang, Shi-Long Liu, et al.. (2025). Nanopore Discriminates Watson–Crick and Hoogsteen Hydrogen Bonds in Multiple DNA Contexts. Nano Letters. 25(4). 1706–1714. 7 indexed citations
2.
Zhang, Ruifan, Huan Li, Dongfeng Li, et al.. (2025). NK1R Antagonist, CP‐99,994 Ameliorates Dry Eye Disease via Inhibiting the Plk1‐Cdc25c‐Cdk1 Axis. Journal of Biochemical and Molecular Toxicology. 39(2). e70177–e70177. 1 indexed citations
3.
Gong, Bo, Huan Li, Dongfeng Li, et al.. (2025). A Silk Fibroin Nanoparticle Hydrogel Loaded With NK1R Antagonist Has Synergistic Anti‐Inflammatory and Reparative Effects on Dry Eye Disease. Advanced Science. 12(15). e2404835–e2404835. 5 indexed citations
4.
Dong, Yang, et al.. (2025). Effects of Using Prompts During Parent–Child Shared Reading on the Language Development of Mildly Autistic Children. Journal of Autism and Developmental Disorders. 1 indexed citations
6.
Wang, Ting, et al.. (2023). Association of variants in GJA8 with familial acorea-microphthalmia-cataract syndrome. European Journal of Human Genetics. 32(4). 413–420. 3 indexed citations
8.
Lu, Shi Yao, Shi Song Rong, Mary Ho, et al.. (2021). Genetic associations of central serous chorioretinopathy: a systematic review and meta-analysis. British Journal of Ophthalmology. 106(11). 1542–1548. 10 indexed citations
9.
Zhu, Xianjun, Bo Gong, Zhenglin Yang, et al.. (2020). G-Protein-Coupled Estrogen Receptor 1 Promotes Gender Disparities in Hepatocellular Carcinoma via Modulation of SIN1 and mTOR Complex 2 Activity. Molecular Cancer Research. 18(12). 1863–1875. 4 indexed citations
10.
He, Zongze, et al.. (2020). CAMTA1, a novel antitumor gene, regulates proliferation and the cell cycle in glioma by inhibiting AKT phosphorylation. Cellular Signalling. 79. 109882–109882. 12 indexed citations
11.
Xiao, Ying, Xiang‐Qin Liu, Chen Yang, et al.. (2019). A Novel PAX6 Heterozygous Mutation Found in a Chinese Family with Congenital Aniridia. Genetic Testing and Molecular Biomarkers. 23(7). 495–500. 4 indexed citations
12.
Gong, Bo, et al.. (2019). [Analysis of FBN1 gene mutations in two pedigrees affected with Marfan syndrome].. PubMed. 36(6). 566–570. 1 indexed citations
13.
Wu, Haiyan, Lingxi Jiang, Rui Zheng, et al.. (2018). Genetic Association Study Between the COL11A1 and COL18A1 Genes and High Myopia in a Han Chinese Population. Genetic Testing and Molecular Biomarkers. 22(6). 359–365. 2 indexed citations
14.
Gong, Bo, Yi Shi, Chao Qu, et al.. (2017). Association of catalase polymorphisms with primary open-angle glaucoma in a Chinese population. Ophthalmic Genetics. 39(1). 35–40. 7 indexed citations
15.
Yang, Xian, Xiaoqi Liu, Jie Peng, et al.. (2014). Evaluation of MYOC , ACAN , HGF , and MET as Candidate Genes for High Myopia in a Han Chinese Population. Genetic Testing and Molecular Biomarkers. 18(6). 446–452. 11 indexed citations
16.
Gong, Bo, et al.. (2013). [Carrier screening for spinal muscular atrophy in 4719 pregnant women in Shanghai region].. PubMed. 30(6). 670–2. 9 indexed citations
17.
Gong, Bo, Jia Chen, Shuang Cao, et al.. (2013). Caprin-1 is a novel microRNA-223 target for regulating the proliferation and invasion of human breast cancer cells. Biomedicine & Pharmacotherapy. 67(7). 629–636. 54 indexed citations
18.
Gong, Bo. (2012). Cell-free DNA in blood is a potential diagnostic biomarker of breast cancer. Oncology Letters. 3(4). 897–900. 27 indexed citations
19.
Gong, Bo, et al.. (2011). The Effect of KCNJ11 Polymorphism on the Risk of Type 2 Diabetes: A Global Meta-Analysis Based on 49 Case-Control Studies. DNA and Cell Biology. 31(5). 801–810. 16 indexed citations
20.
Liu, Mingna, Bo Gong, & Zhi Qi. (2008). Comparison of the endogenous IK currents in rat hippocampal neurons and cloned Kv2.1 channels in CHO cells. Cell Biology International. 32(12). 1514–1520. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026